Hikma Pharmaceuticals plans USD1 billion investment to support US unit
(Alliance News) - Hikma Pharmaceuticals PLC has pledged to invest USD1 billion by 2030 to further expand its US manufacturing and R&D capabilities. Read More
Price | 1,976.00p on 09-07-2025 | at 06:15:08
---|---|
Change | 0.00p 0% |
Buy | 2,200.00p |
Sell | 0.00p |
Buy / Sell HIK Shares |
Last Trade: | Unknown 5,921.00 at 1,976.00p |
Day's Volume: | 0 |
Last Close: | 1,976.00p |
Open: | 0.00p |
ISIN: | GB00B0LCW083 |
Day's Range | 0.00p - 0.00p |
52wk Range: | 1,751.00p - 2,360.00p |
Market Capitalisation: | £4,356m |
VWAP: | 0.00p |
Shares in Issue: | 220m |
Hikma Pharmaceuticals (HIK) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Unknown* | 5,921 | 1,976.00p | SI Trade |
17:50:21 - 08-Jul-25 |
Sell* | 17,169 | 1,975.482p | SI Trade Suspected SELL Trade |
16:47:01 - 08-Jul-25 |
Buy* | 23,665 | 1,976.019p | SI Trade Negotiated Trade |
16:36:33 - 08-Jul-25 |
Buy* | 15 | 1,976.00p | SI Trade |
16:35:29 - 08-Jul-25 |
Unknown* | 4,671 | 1,976.00p | OTC Trade |
16:35:29 - 08-Jul-25 |
Unknown* | 1,741 | 1,976.00p | OTC Trade |
16:35:29 - 08-Jul-25 |
Unknown* | 560 | 1,976.00p | OTC Trade |
16:35:29 - 08-Jul-25 |
Unknown* | 209 | 1,976.00p | OTC Trade |
16:35:29 - 08-Jul-25 |
Sell* | 2 | 1,976.00p | Automatic Execution |
16:35:29 - 08-Jul-25 |
Sell* | 6,992 | 1,976.00p | Automatic Execution |
16:35:29 - 08-Jul-25 |
Hikma Pharmaceuticals (HIK) Regulatory News |
||
Date | Source | Headline |
---|---|---|
7th Jul 2025 9:16 am | RNS | Publication of Offering Circular |
9th Jun 2025 3:33 pm | RNS | Director/PDMR Shareholding |
5th Jun 2025 2:05 pm | RNS | Director/PDMR Shareholding |
3rd Jun 2025 1:02 pm | RNS | Director/PDMR Shareholding |
29th May 2025 7:00 am | RNS | Fitch upgrades Hikma to ‘BBB’ |
20th May 2025 2:49 pm | RNS | Director/PDMR Shareholding |
15th May 2025 12:00 pm | RNS | Medium-term Group guidance ahead of US site visit |
8th May 2025 4:35 pm | RNS | Director/PDMR Shareholding |
8th May 2025 10:48 am | RNS | S&P upgrades Hikma to ‘BBB’ |
8th May 2025 8:21 am | RNS | Settlement agreement for Xyrem® US lawsuits |